AI Assistant
Blog
Pricing
Log In
Sign Up
High-dose celecoxib does not improve survival of patients with differentiated thyroid cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
